Outlook Therapeutics Inc
F:41O
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outlook Therapeutics Inc
F:41O
|
US |
|
Koninklijke Philips NV
AEX:PHIA
|
NL |
|
Bourse Direct SA
F:BD6
|
FR |
|
C
|
Caesars Entertainment Inc
F:2ER
|
US |
|
Impala Platinum Holdings Ltd
F:IPH1
|
ZA |
|
C
|
Carlsberg A/S
XMUN:CBGB
|
DK |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
M
|
Mitsui Fudosan Co Ltd
XMUN:MFU
|
JP |
|
Italgas SpA
MIL:IG
|
IT |
|
A
|
Absolute Clean Energy PCL
SET:ACE
|
TH |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
Wall St Price Targets
41O Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 41O is 3.72 EUR with a low forecast of 0.33 EUR and a high forecast of 6.96 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41O's stock price target?
Price Target
3.72
EUR
According to Wall Street analysts, the average 1-year price target for 41O is 3.72 EUR with a low forecast of 0.33 EUR and a high forecast of 6.96 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
558%
The compound annual growth rate for Gross Profit over the next 3 years is 558%.
